Searched for
FRESENIUS FRANCE
Nestle replaces CEO Schneider with company veteran FreixeNestle has announced the replacement of its CEO Mark Schneider with Laurent Freixe, a company veteran, effective from Sept. 1. Schneider, w...- European stocks edge up as Novo Nordisk offsets luxury sector jittersEuropean stocks inched higher on Wednesday as Novo Nordisk shares jumped after a positive update on its diabetes drug Ozempic, though under...
- European stocks gain on tech and luxury boost, but set for weekly lossesThe pan-European STOXX 600 index rose 0.2 per cent, but was still on course to end the week 0.7 per cent lower amid persisting worries of a...
- Sun Pharma starts rollout of Gemcitabine InfuSMART in six European nationsGemcitabine is indicated in the treatment of ovarian, lung, breast and pancreatic cancer. Sun Pharma hinted at more oncology products being...
- FDI up to 74% in brownfield pharma under automatic routeThe government today allowed up to 74 per cent foreign direct investment in the existing pharmaceutical companies through automatic route.
- Government weighs relaxing FDI norms in brownfield pharma companiesAccording to a proposal, FDI up to 49% should be allowed through the automatic route and anything beyond through approval of the FIPB, sour...
- Government to conduct study to assess impact of FDI in pharma industryThe experts would look into the impact of foreign direct investment in the brownfield pharmaceutical companies and access to affordable med...
- Government to commission study on impact of FDI in pharmaceutical companiesThe government is likely to commission a study soon to assess the impact of foreign direct investment in existing pharmaceutical companies
- How does the Sun Pharma-Ranbaxy deal change the game for the other players in the Indian pharma market?The combined market share of Sun Pharma (5.4% at present) and Ranbaxy (3.8%) will be 9.2%; much higher than that of the current No. 1 playe...
- Sun Pharma-Ranbaxy combine creates a new market leader in Indian marketThe proposed new entity would unseat Abbott from the top position, which holds current market share of 6.5%, according to research firm Aio...
- Govt to review FDI policy in pharma sector on MondayGovernment will take up the issue of tightening FDI in existing pharmaceutical companies in the wake of concerns over multinationals taking...
- DIPP for stringent conditions in FDI in existing pharma companiesThe total investment as per the condition proposed would have to incurred within 3 years of the acquisition, they said.
- Finance ministry asked not to clear pharma FDI proposalsThe move threatens to bring foreign direct investment into the sector to a standstill that had only begun to see activity after PM himself ...
- DIPP wants relook of FDI policy in pharma at PM levelWith no let up in multinationals seeking nod to acquire stake in Indian pharma firms despite government putting norms to check it.
- FDI in pharma sector faces fresh headwinds with DIPPDepartment of Industrial Policy and Promotion seeks review of the policy barely months after it was cleared at the intervention of the PM.
- CCI seeks changes in Competition Act to deal with all M&AsThe government, he added, should amend the law in such a way so that it can have powers to prescribe different threshold limits for M&As fo...
- Prime Minister Manmohan singh likely to take meeting on FDI in pharmaceutical tomorrowNo consensus could emerge in the report of the committee which had senior officials from the ministries of health, industry law finance bes...
- Let all pharmaceutical mergers and acquisitions be cleared by CCI: Plan panel groupA Planning Commission expert group recommended that all M&As in the pharma industry should be cleared by CCI.
- ‘More generic cos keen on selling out to MNCs’The founding families of many of India’s drug companies want to sell their businesses finding that it is difficult to grow them by relying ...
- Founders of many Indian pharma companies keen to exit: MalvinderTHE founding families of many of India’s drug companies want to sell their businesses, finding that it is difficult to grow them by relying...
Load More
